BackEntero Therapeutics Overview

Entero Therapeutics Short-Term Investments

Entero Therapeutics's short-term investments is $0.

Get informed when a big investor buys or sells

+ Follow
Short-Term Investments
$0.00

Peer trimmed avg / median

Loading

Entero Therapeutics Short-Term Investments History

Loading

Entero Therapeutics vs. peers: Short-Term Investments Comparison

Loading

Entero Therapeutics Short-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Entero Therapeutics (ENTO) FAQ

The latest short-term investments for ENTO is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Entero Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ENTO's short-term investments moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Entero Therapeutics's operating scale or balance-sheet position.

A short-term investments figure of $0 for ENTO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ENTO's short-term investments ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.